Key facts
- Quastella’s last known valuation is $2.5M (Jul 2025).
- It has raised $900K; the latest was Later Stage VC ($900K) in Jul 2025.
- Notable investors include Incubate Fund, Dual Bridge Capital, Aichi Capital, Aichi Deeptech Launchpad, Central Japan Startup Ecosystem — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Quastella
- ·The full record, as it builds
Funding rounds
No funding rounds for Quastella are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Quastella
Developer of a quality control technology intended for industries to revitalize things and people all over the earth. The company's technology provides an engineering system for advanced quality control of living cells, as well as for data construction, data analysis, and data utilization, and creates a global standard for control, enabling clients, companies, and industries to monitor records by fingerprinting images that record cell states, optimization by comparing records, and quantitative advanced prediction of cell quality.
- Sector
- Healthcare
- HQ
- Nagoya, Japan
- Founded
- 2019
- Employees
- 10
- Website
- quastella.com/
- Ownership
- Privately Held (backing)
Quastella doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Quastella shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Quastella in its N-PORT filings yet. We sweep new filings monthly.